Hjem › Cystisk fibrose › Kansas › Kansas City
Kliniske studier for Cystisk fibrose i Kansas City, KS
13 studier for Cystisk fibrose søker deltakere på steder i og rundt Kansas City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
RekruttererFase 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
RekruttererFase 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
RekruttererFase 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
RekruttererFase 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
RekruttererObservasjonsstudie
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RekruttererObservasjonsstudie
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RekruttererFase 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
RekruttererFase 1/2
- University of Kansas Medical Center, Kansas City
Cystisk fibrose-studier i andre byer
- Boston, MA17 studier
- Birmingham, AL16 studier
- Philadelphia, PA15 studier
- Seattle, WA12 studier
- Baltimore, MD12 studier
- Denver, CO11 studier
- Pittsburgh, PA11 studier
- Dallas, TX11 studier
- Cincinnati, OH10 studier
- Los Angeles, CA9 studier
- Aurora, CO9 studier
- Minneapolis, MN8 studier
Andre studier i Kansas City
- Kardiovaskulær sykdom14 studier
- Hjertesvikt13 studier
- Fedme13 studier
- Interstitielle lungesykdommer13 studier
- Brystkreft12 studier
- Blærekreft12 studier
- Akut myelogen leukemi12 studier
- Prostatakreft12 studier
- Ikke-småcellet lungekreft11 studier
- Lungekreft11 studier
- KOLS9 studier
- Astma8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.